📰 Micron News
Page 12 - Micron News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Micron. Real-time updates on events, politics, business and more.
April 26, 2024
President Joe Biden announced that the Department of Commerce has reached a preliminary agreement with Micron Technology, Inc. to provide $6. 14 billion in direct funding under the CHIPS and Science Act.
April 26, 2024
BoiseDev reports officials with Micron Technology, President Joe Biden, Gov. Brad Little, Boise Mayor Lauren McLean, and others will appear at an event in Syrac
April 25, 2024
Microns CHIPS Act grant will support manufacturing of a commodity product - memory chips, that are vital in the age of AI.
April 25, 2024
U.S. President Joe Biden will travel to Syracuse, New York, on Thursday to announce a preliminary agreement with memory chip maker Micron Technology for up to $6.14 billion in subsidies for two chip factories, the White House said.
April 25, 2024
A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to a Brazilian study reported in the Journal of Medical Virology.
April 25, 2024
Micron also anticipates hefty tax credits and billions of dollars in incentives, all of which will go towards a new fab in Idaho and two new fabs in New York.
April 24, 2024
A tARC-seq approach to precisely determine SARS-CoV-2 mutation frequency.
April 23, 2024
President Joe Biden is scheduled to visit Syracuse this Thursday following the announcement that Micron will receive $6.1 billion under the Chips and Science Act.
April 23, 2024
TOKYO -- The head of New York's economic development agency is working to draw investment from Japanese chip industry suppliers as the state seeks to
April 21, 2024
New research to be presented at next week's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) highlights the risk of new immune-evasive SARS-CoV-2 variants emerging in immunocompromised patients.